Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Stroke Assistive Devices Market

ID: MRFR/Pharma/14344-HCR
100 Pages
Rahul Gotadki
Last Updated: April 06, 2026

US Stroke Assistive Devices Market Research Report By Type (Mobility Assistive Devices, Fixed Assistive Devices, Communication Devices, Cognitive Devices), By Application (Hospitals, Specialty Clinics, Physiotherapy Centers, Ambulatory Surgical Centers, Home Care Settings, Rehabilitation Centers, Others) and By Distribution Channel (Direct Sales, Online Sales, Retail Pharmacies, Medical Stores) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Stroke Assistive Devices Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Medical Device, BY Type (USD Million)
  49.     4.1.1 Mobility Assistive Devices
  50.     4.1.2 Fixed Assistive Devices
  51.     4.1.3 Communication Devices
  52.     4.1.4 Cognitive Devices
  53.   4.2 Medical Device, BY Application (USD Million)
  54.     4.2.1 Hospitals
  55.     4.2.2 Specialty Clinics
  56.     4.2.3 Physiotherapy Centers
  57.     4.2.4 Ambulatory Surgical Centers
  58.     4.2.5 Home Care Settings
  59.     4.2.6 Rehabilitation Centers
  60.     4.2.7 Others
  61.   4.3 Medical Device, BY Distribution Channel (USD Million)
  62.     4.3.1 Direct Sales
  63.     4.3.2 Online Sales
  64.     4.3.3 Retail Pharmacies
  65.     4.3.4 Medical Stores
  66. 5 SECTION V: COMPETITIVE ANALYSIS
  67.   5.1 Competitive Landscape
  68.     5.1.1 Overview
  69.     5.1.2 Competitive Analysis
  70.     5.1.3 Market share Analysis
  71.     5.1.4 Major Growth Strategy in the Medical Device
  72.     5.1.5 Competitive Benchmarking
  73.     5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  74.     5.1.7 Key developments and growth strategies
  75.       5.1.7.1 New Product Launch/Service Deployment
  76.       5.1.7.2 Merger & Acquisitions
  77.       5.1.7.3 Joint Ventures
  78.     5.1.8 Major Players Financial Matrix
  79.       5.1.8.1 Sales and Operating Income
  80.       5.1.8.2 Major Players R&D Expenditure. 2023
  81.   5.2 Company Profiles
  82.     5.2.1 Medtronic (US)
  83.       5.2.1.1 Financial Overview
  84.       5.2.1.2 Products Offered
  85.       5.2.1.3 Key Developments
  86.       5.2.1.4 SWOT Analysis
  87.       5.2.1.5 Key Strategies
  88.     5.2.2 Boston Scientific (US)
  89.       5.2.2.1 Financial Overview
  90.       5.2.2.2 Products Offered
  91.       5.2.2.3 Key Developments
  92.       5.2.2.4 SWOT Analysis
  93.       5.2.2.5 Key Strategies
  94.     5.2.3 Abbott Laboratories (US)
  95.       5.2.3.1 Financial Overview
  96.       5.2.3.2 Products Offered
  97.       5.2.3.3 Key Developments
  98.       5.2.3.4 SWOT Analysis
  99.       5.2.3.5 Key Strategies
  100.     5.2.4 B. Braun Melsungen AG (DE)
  101.       5.2.4.1 Financial Overview
  102.       5.2.4.2 Products Offered
  103.       5.2.4.3 Key Developments
  104.       5.2.4.4 SWOT Analysis
  105.       5.2.4.5 Key Strategies
  106.     5.2.5 Stryker Corporation (US)
  107.       5.2.5.1 Financial Overview
  108.       5.2.5.2 Products Offered
  109.       5.2.5.3 Key Developments
  110.       5.2.5.4 SWOT Analysis
  111.       5.2.5.5 Key Strategies
  112.     5.2.6 Johnson & Johnson (US)
  113.       5.2.6.1 Financial Overview
  114.       5.2.6.2 Products Offered
  115.       5.2.6.3 Key Developments
  116.       5.2.6.4 SWOT Analysis
  117.       5.2.6.5 Key Strategies
  118.     5.2.7 C.R. Bard (US)
  119.       5.2.7.1 Financial Overview
  120.       5.2.7.2 Products Offered
  121.       5.2.7.3 Key Developments
  122.       5.2.7.4 SWOT Analysis
  123.       5.2.7.5 Key Strategies
  124.     5.2.8 Smith & Nephew (GB)
  125.       5.2.8.1 Financial Overview
  126.       5.2.8.2 Products Offered
  127.       5.2.8.3 Key Developments
  128.       5.2.8.4 SWOT Analysis
  129.       5.2.8.5 Key Strategies
  130.     5.2.9 Thermo Fisher Scientific (US)
  131.       5.2.9.1 Financial Overview
  132.       5.2.9.2 Products Offered
  133.       5.2.9.3 Key Developments
  134.       5.2.9.4 SWOT Analysis
  135.       5.2.9.5 Key Strategies
  136.   5.3 Appendix
  137.     5.3.1 References
  138.     5.3.2 Related Reports
  139. 6 LIST OF FIGURES
  140.   6.1 MARKET SYNOPSIS
  141.   6.2 US MARKET ANALYSIS BY TYPE
  142.   6.3 US MARKET ANALYSIS BY APPLICATION
  143.   6.4 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  144.   6.5 KEY BUYING CRITERIA OF MEDICAL DEVICE
  145.   6.6 RESEARCH PROCESS OF MRFR
  146.   6.7 DRO ANALYSIS OF MEDICAL DEVICE
  147.   6.8 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
  148.   6.9 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
  149.   6.10 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
  150.   6.11 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
  151.   6.12 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
  152.   6.13 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
  153.   6.14 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
  154.   6.15 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  155.   6.16 MEDICAL DEVICE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
  156.   6.17 BENCHMARKING OF MAJOR COMPETITORS
  157. 7 LIST OF TABLES
  158.   7.1 LIST OF ASSUMPTIONS
  159.     7.1.1
  160.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  161.     7.2.1 BY TYPE, 2025-2035 (USD Million)
  162.     7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  163.     7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
  164.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  165.     7.3.1
  166.   7.4 ACQUISITION/PARTNERSHIP
  167.     7.4.1

US Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

  • Mobility Assistive Devices
  • Fixed Assistive Devices
  • Communication Devices
  • Cognitive Devices

Medical Device By Application (USD Million, 2025-2035)

  • Hospitals
  • Specialty Clinics
  • Physiotherapy Centers
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Rehabilitation Centers
  • Others

Medical Device By Distribution Channel (USD Million, 2025-2035)

  • Direct Sales
  • Online Sales
  • Retail Pharmacies
  • Medical Stores

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions